SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: DanZ who wrote (2869)10/26/2000 12:40:57 PM
From: Hank  Read Replies (2) | Respond to of 5582
 
"Swedish Match included Gum Tech in the section on their most important acquisitions."

And where else would you have them put it Danny Boy? Seems like it belongs in that section to me. Simply standard reporting practice. It amazes how you can read so much into absolutely nothing.

"Doesn't that say something about how important the joint venture with Gum Tech is?"

No. Standard protocol you idiot.

"This stock doesn't even come close to reflecting the value of the JV with Swedish Match, much less the value of Gel Tech."

Looks like nobody believes you, as usual. Next stop, new 52 week low!!!



To: DanZ who wrote (2869)10/26/2000 12:57:20 PM
From: Eric Fader  Respond to of 5582
 
Dan, I'm focused primarily on Zicam, as you know, so I've lost track of the Swedish Match sales projections/wild guesses. Would you either repeat 'em or post a link to the most recent speculation on the sizes of the markets they'll be targeting? TIA - Eric